Brandywine Realty Trust Announces Second Quarter Results And Narrows 2021 Guidance

NEXT STORY
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
PREV STORY
Biogen and Eisai Announce ADUHELM™ (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Update on RX-3117 Development

author_avatar
NASDAQ Market News

UPDATE – electroCore Appoints Multiple Industry Veterans to Key Management Positions

author_avatar
NASDAQ Market News

Barbarian XL Review: Negative Side Effects or Real Benefits?

author_avatar
NASDAQ Market News